Zacks Investment Research
Omnicell (OMCL) Q3 Earnings and Revenues Top Estimates
Omnicell reported Q3 2026 earnings of $0.58 per share, beating consensus estimates of $0.42 by 38.10%, with revenues of $307.85 million slightly exceeding expectations. However, the stock has underperformed the S&P 500 by 33.7% year-to-date.
The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. The Medical Info Systems industry ranks in the top 38% of Zacks industries.
